Abstract:Background: Although the close relationship between nonalcoholic fatty liver disease (NAFLD) and insulin resistance has been clarified and there is a five-fold higher prevalence of NAFLD in patients with diabetes compared to that in patients without diabetes, this is not a reason to focus only on the incidence of NAFLD in people with diabetes because people who are insulin resistant are not necessarily diagnosed with diabetes, which leads to the overlook of NAFLD in non-diabetic population. Actually, we are obligated to pay more attention to the non-diabetic population for early detection and intervention of NAFLD. There is a lack of a convenient tool for predicting NAFLD in non-diabetic adults, and thus we aim to develop and validate a novel clinical nomogram to predict NAFLD among non-diabetic population to save more medical resources and make less missed diagnosis. Methods: Researchers initially enrolled 20,944 patients and excluded those with history of drinking, known medication usage, viral hepatitis, known liver disease, missing covariant data, age <18 years, and impaired fasting blood glucose, leaving 14,251 adults participating in the baseline analysis, who were randomly divided in a ratio of 3:1 into a training dataset with 10,689 participants and a validation dataset with 3,562 participants, using the classification and regression training (caret) package in R software v. 4.0.3. Variables for prediction were selected by multivariable logistic regression analysis, the LASSO method, and clinical experience. Based on these, we constructed a prediction model. Performance of this model was validated by the area under the receiver operator characteristic curve, calibration curve, and decision curve analysis. Results: We used 6 variables to construct the prediction model: body mass index (BMI), aspartate aminotransferase (AST), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), hemoglobin A1c (HbA1c), and diastolic blood pressure (DBP). In the training and validation datasets, the AUROC value of this prediction was 0.891 [95% confidence interval (CI): 0.884 to 0.899] and 0.902 (95% CI: 0.890 to 0.914), respectively. The calibration plots and the decision curve analysis (DCA) demonstrated that the accuracy of this model was good, with high clinical practicability. Conclusions: The nomogram could screen non-diabetic adults for NAFLD and may aid clinical decision-making.

Development and Validation of an Algorithm to Identify Nonalcoholic Fatty Liver Disease in the Electronic Medical Record

NAFL Screening Score: A Basic Score Identifying Ultrasound-Diagnosed Non-Alcoholic Fatty Liver

Electronic Medical Records for Discovery Research in Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (NAFLD) in the Veterans Administration population: development and validation of an algorithm for NAFLD using automated data

Application of Machine Learning Techniques for Clinical Predictive Modeling: A Cross-Sectional Study on Nonalcoholic Fatty Liver Disease in China

A Machine Learning Based Framework to Identify and Classify Non-alcoholic Fatty Liver Disease in a Large-Scale Population

Development and Validation of a Novel Non-Invasive Test for Diagnosing Nonalcoholic Fatty Liver Disease in Chinese Children

Development and validation of machine learning models for nonalcoholic fatty liver disease

Comparison and development of advanced machine learning tools to predict nonalcoholic fatty liver disease: An extended study

Development and validation of a risk score for detecting non-alcoholic fatty liver disease

Using An Electronic Medical Records Database To Identify Non-Traditional Cardiovascular Risk Factors In Nonalcoholic Fatty Liver Disease

Automated machine learning models for nonalcoholic fatty liver disease assessed by controlled attenuation parameter from the NHANES 2017-2020

Ultrasound‐Based Machine Learning Approach for Detection of Nonalcoholic Fatty Liver Disease

Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver disease

A Novel Model for Predicting Fatty Liver Disease by Means of an Artificial Neural Network

Development and validation study of a non-alcoholic fatty liver disease risk scoring model among adults in China

Development and Validation of a Nomogram for Predicting Nonalcoholic Fatty Liver Disease in the Non-Obese Chinese Population

A Predictive Model for the Diagnosis of Non-Alcoholic Fatty Liver Disease Based on an Integrated Machine Learning Method.

A Clinical and Laboratory-Based Nomogram for Predicting Nonalcoholic Fatty Liver Disease in Non-Diabetic Adults: a Cross-Sectional Study.

LEARN Algorithm: a Novel Option for Predicting Non-Alcoholic Steatohepatitis

Development and validation of an online dynamic nomogram based on the atherogenic index of plasma to screen nonalcoholic fatty liver disease